Rx only
For topical use only
Not for ophthalmic use
Umecta is a keratolytic, emollient which is a gentle, yet potent, tissue softener for nails and skin
Each gram of Umecta® topical suspension contains 40% urea, butylated hydroxytoluene, butyrospermum parkii fruit oil, disodium EDTA, glyceryl stearate, glycine soja sterol, helianthus annuus oil, purified water, stearic
acid, sodium polyacrylate, and triethanolamine.
Clinical Pharmacology
Urea gently dissolves the intercellular matrix which results in loosening the horny layer of skin and shedding scaly skin at regular intervals, thereby softening hyperkeratotic areas. Urea also hydrates and gently dissolves the intercellular matrix of the nail plate which can result in the softening and eventual debridement of the nail plate.
Pharmacokinetics
The mechanism of action of topically applied urea is not yet known.
Indications and Uses
For debridement and promotion of normal healing of hyperkeratotic surface lesions, particularly where healing is retarded by local infection, necrotic tissue, fibrinous or purulent debris or eschar. Urea is useful for the treatment of hyperkeratotic conditions such as dry, rough skin, dermatitis, psoriasis, xerosis, ichthyosis, eczema, keratosis, keratoderma, corns, and calluses, as well as damaged, ingrown and devitalized nails.
Contraindications
Known hypersensitivity to any of the listed ingredients.
Warnings
For external use only. Avoid contact with eyes, lips or mucous membranes.
Precautions
This medication is to be used as directed by a physician and should not be used to treat any condition other than that for which it was prescribed. If redness or irritation occurs, discontinue use.
Pregnancy Category C
Animal reproduction studies have not been conducted with Umecta. It is also not known whether Umecta can cause fetal harm when administered to a pregnant woman or can affect reproductive capacity. Umecta should be given to a pregnant woman only if clearly needed.
Nursing Mothers
It is not known whether or not this drug is secreted in human milk. Because many drugs are secreted in human milk, caution should be exercised when Umecta is administered to a nursing woman.
KEEP THIS AND ALL MEDICATIONS OUT OF THE REACH OF CHILDREN.
Adverse Reactions
Transient stinging, burning, itching, or irritation may occur and normally disappear on discontinuing the medication.
Dosage and Administration
Apply Umecta Topical Suspension to affected skin twice per day or as directed by a physician. Rub in until completely absorbed.
How Supplied
Umecta® (urea, 40%) topical suspension supplied in a:
10 oz. bottle (topical suspension)
NDC 68712-005-01
Manufactured for:
Innocutis Holdings, LLC.
Charleston, SC 29401
Toll Free: 1-800-499-4468
www.innocutis.com
www.umecta.com
UMECTA UREA urea suspension | ||||||||||||||||||||||
| ||||||||||||||||||||||
| ||||||||||||||||||||||
| ||||||||||||||||||||||
| ||||||||||||||||||||||
|
Marketing Information | |||
Marketing Category | Application Number or Monograph Citation | Marketing Start Date | Marketing End Date |
unapproved drug other | 06/01/2004 |
Labeler - Innocutis Holdings, LLC (071501252) |
Establishment | |||
Name | Address | ID/FEI | Operations |
Ei Inc. | 105803274 | manufacture |
More Umecta Topical Suspension resources
- Umecta Topical Suspension Side Effects (in more detail)
- Umecta Topical Suspension Use in Pregnancy & Breastfeeding
- Umecta Topical Suspension Support Group
- 0 Reviews for Umecta Topical - Add your own review/rating
Compare Umecta Topical Suspension with other medications
- Dermatological Disorders
- Dry Skin
- Pityriasis rubra pilaris
No comments:
Post a Comment